Q1 2025 Earnings Estimate for Encompass Health Co. (NYSE:EHC) Issued By William Blair

Encompass Health Co. (NYSE:EHC) – Analysts at William Blair upped their Q1 2025 EPS estimates for Encompass Health in a research note issued on Wednesday, April 24th. William Blair analyst J. Haase now expects that the company will post earnings of $1.30 per share for the quarter, up from their previous estimate of $1.03. William Blair has a “Outperform” rating on the stock. The consensus estimate for Encompass Health’s current full-year earnings is $4.10 per share.

Several other brokerages also recently weighed in on EHC. Barclays lifted their price target on shares of Encompass Health from $101.00 to $108.00 and gave the company an “overweight” rating in a report on Thursday, April 25th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $83.00 price target on shares of Encompass Health in a report on Friday, February 9th. Truist Financial lifted their price target on shares of Encompass Health from $82.00 to $86.00 and gave the company a “buy” rating in a report on Friday, February 9th. Stephens reaffirmed an “overweight” rating and set a $85.00 price target on shares of Encompass Health in a report on Tuesday, January 16th. Finally, Mizuho boosted their target price on shares of Encompass Health from $93.00 to $95.00 and gave the stock a “buy” rating in a report on Thursday, April 25th. Eight analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Buy” and an average target price of $88.13.

Encompass Health Price Performance

Shares of NYSE:EHC opened at $83.41 on Monday. The company has a debt-to-equity ratio of 1.14, a current ratio of 1.37 and a quick ratio of 1.28. Encompass Health has a 1-year low of $57.55 and a 1-year high of $85.84. The company has a market capitalization of $8.35 billion, a P/E ratio of 22.54, a P/E/G ratio of 1.34 and a beta of 0.94. The firm’s 50 day simple moving average is $78.64 and its two-hundred day simple moving average is $71.25.

Encompass Health (NYSE:EHC) last announced its earnings results on Wednesday, April 24th. The company reported $1.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.93 by $0.19. The company had revenue of $1.32 billion during the quarter, compared to analyst estimates of $1.27 billion. Encompass Health had a net margin of 7.60% and a return on equity of 18.01%. The firm’s quarterly revenue was up 13.4% compared to the same quarter last year. During the same period in the previous year, the business posted $0.88 earnings per share.

Encompass Health Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Monday, April 15th. Stockholders of record on Monday, April 1st were issued a $0.15 dividend. This represents a $0.60 annualized dividend and a dividend yield of 0.72%. The ex-dividend date of this dividend was Thursday, March 28th. Encompass Health’s dividend payout ratio (DPR) is presently 16.22%.

Institutional Investors Weigh In On Encompass Health

Large investors have recently bought and sold shares of the business. Principal Securities Inc. bought a new stake in Encompass Health in the fourth quarter worth $25,000. Benjamin F. Edwards & Company Inc. increased its position in Encompass Health by 360.2% in the fourth quarter. Benjamin F. Edwards & Company Inc. now owns 405 shares of the company’s stock worth $27,000 after purchasing an additional 317 shares during the last quarter. McGlone Suttner Wealth Management Inc. bought a new stake in Encompass Health in the fourth quarter worth $30,000. GAMMA Investing LLC bought a new stake in Encompass Health in the fourth quarter worth $33,000. Finally, C M Bidwell & Associates Ltd. bought a new stake in Encompass Health in the third quarter worth $35,000. Institutional investors own 97.25% of the company’s stock.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.